Sai Karan Vamsi Guda, DO
Critical Care Medicine · Fort Worth, TXNPI 1023491255
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (31.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.7% of it on its own, with 32 other manufacturers making up the rest. Among critical care medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $220.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$33K
- Pulmonx Corporation$9K
- Boston Scientific$1K
- Sanofi$525
- Galvanize Therapeutics, Inc$315
- Ambu Inc.$299
- plus $2K from 27 others
What the payments were for
- Consulting fees$5,52512%
- Speaking & faculty fees$14,00030%
- Travel & lodging$4,1349%
- Food & beverage$8,23918%
- Education$14,54831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 56 | $33,283 |
| Pulmonx Corporation | 31 | $8,580 |
| Boston Scientific | 16 | $1,015 |
| Sanofi | 11 | $525 |
| Galvanize Therapeutics, Inc | 3 | $315 |
| Ambu Inc. | 5 | $299 |
| Olympus America Inc. | 6 | $285 |
| AstraZeneca | 14 | $254 |
| Steris Corporation | 2 | $247 |
| GSK | 8 | $146 |
| Baxter Healthcare | 6 | $131 |
| Pinnacle Biologics, Inc | 1 | $130 |
| Advanced Respiratory, Inc | 1 | $123 |
| Abiomed | 1 | $119 |
| Boehringer Ingelheim | 5 | $116 |
| Insmed, Inc. | 6 | $108 |
| Mylan Specialty L.p. | 4 | $88 |
| Shionogi Inc | 4 | $82 |
| Actelion Pharmaceuticals US, Inc. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Body Vision Medical Inc. | 4 | $60 |
| AbbVie | 3 | $56 |
| Novartis | 3 | $54 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Amgen | 2 | $41 |
| Merck | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Cumberland Pharmaceuticals, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Philips North America LLC | 1 | $19 |
| Electromed, Inc. | 1 | $16 |
| Eurofins Viracor, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$20,351
- DA VINCI SP$12,150
- ZEPHYR ENDOBRONCHIAL VALVE$7,889
- CHARTIS CATHETER$6,320
- ZEPHYR DELIVERY CATHETER$6,320
- PULMONX CHARTIS TABLET CONSOLE$6,320
- ACQUIRE$395
- DUPIXENT$329
- ALIYA SYSTEM$275
- TRUFREEZE$158
- Single-Use flexible Video Bronchoscope$135
- Photofrin$130
- The Vest System Model 105 Home Care$123
How this compares
$46,446 in reported general payments places this provider in the 95th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $36,581 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $12,180 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $5,911 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $733 |
| Prednisone | 48 | $262 |
| Montelukast Sodium | 14 | $197 |
| Azithromycin | 29 | $139 |
| Methylprednisolone | 14 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $146 | $36,58130 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $254 | $18,09126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 507 critical care medicine providers in Texas.
Other critical care medicine in Fort Worth
- Steven DavidoffPlano$364K
- William BartekAustin$284K
- Edwin ParsleyHouston$283K
- Hector PayanEl Paso$245K
- Bindu AkkantiHouston$185K
- Faisal MasudHouston$155K
- Sergio Trevino CastilloHouston$133K
- Akinyinka AjelabiKingwood$109K
- Anthony OrtegonDallas$106K
- Gary WeinsteinDallas$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.